Professor Gino Martini, Chair in Pharmaceutical Innovation, Department of Pharmacy & Forensic Science, King's College London.
Pharmacist and chair of the board of directors for Novartis, Joerg Reinhardt, sits down with the Royal Pharmaceutical Society’s chief scientist, Gino Martini, to discuss his career success to date, the challenges facing the pharmaceutical industry and his future vision for Novartis.
UK drug regulator chair Sir Michael Rawlins on supplies of medicines after Brexit, POM-to-P switches and the legalisation of medical cannabis.
Gino Martini, a representative of the RPS Pharmaceutical Sciences External Advisory Panel and recently appointed chair of the RPS Industrial Pharmacy Forum, discusses the increasingly important impact of personalised medicines on pharmacists and other healthcare professionals.
Recent blog posts
Patients require different combinations of drugs at different doses. Gino Martini explains how ‘polypills’ may enable patients to take one tablet containing the medicines and doses appropriate for them.